Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Moxifloxacin Ocular Penetration in Corneal Transplant
NCT00764582Phase 4Terminated
- Sponsor
- Santen Pharmaceutical
- Start
- Sep 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in Bacterial ocular infection, sponsored by Santen Pharmaceutical. Started Sep 2008; status: terminated.
02
Drugs
levofloxacin
03
Conditions
Bacterial ocular infection
Beyond the preview
Go deeper on NCT00764582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764582.